<qa>  What is SARGRAMOSTIMs REDUCING GRAFT-VERSUS-SARGRAMOSTIM IN REDUCING GRAFT-VERSUS-HOST DISEASE IN PATIENTS WHO ARE UNDERGOING DONOR STEM CELL TRANSPLANTATION FOR HEMATOLOGIC CANCER OR APLASTIC ANEMIA: 